Latest Neuroactive steroid Stories
Neuroscience researchers from Tufts have demonstrated, for the first time, that the physiological response to stress depends on neurosteroids acting on specific receptors in the brain, and they have been able to block that response in mice.
NEW HAVEN, Conn., April 13, 2011 /PRNewswire/ -- Marinus Pharmaceuticals, Inc., the leader in the development of neurosteroids for central nervous system disorders, today announced the award of a $3 million grant by the U.S.
NEW HAVEN, Conn., April 7, 2011 /PRNewswire/ -- Marinus Pharmaceuticals, Inc., the leader in development of neurosteroids for central nervous system disorders, today announced that the United States Patent and Trademark Office (USPTO) issued the company Patent Number 7,858,609 entitled, "Solid ganaxolone formulations and methods for the making and use thereof." The patent describes a novel class of small molecules to improve stability and bioavailability of nanoparticulate formulations of...
One of the ways in which alcohol dependence (AD) may develop is through alcohol's effects on neural signaling, such as modulation of Î³-aminobutyric acid type A (GABAA) receptors.
Findings with Newly Returning Veterans NASHVILLE, Tenn., Dec. 8 /PRNewswire-USNewswire/ -- Veterans of Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) frequently experience high rates of PTSD along with symptoms of depression and pain.
Treatment with the over-the-counter hormonal therapy DHEA (dehydroepiandrosterone) may be effective in treating midlife-onset minor and major depression, according to a study in the February issue of the journal Archives of General Psychiatry.